Outcomes of psychotic disorders are associated with high personal, familiar, societal, and clinical burden. Thus, there is an urgent clinical and societal need for improving outcomes of psychosis. Research findings from the past 2 decades have opened new opportunities for ameliorating outcomes of psychosis through indicated primary prevention in individuals at clinical high risk for psychosis (CHR-P). Indicated primary prevention in individuals at CHR-P can result in (1) delayed or prevented onset of first episode. Furthermore, secondary prevention in individuals at CHR-P who will later develop the disorder may also (2) reduce the duration of untreated psychosis, hospital admission, and compulsory admission1 and (3) improve early detection and ameliorate the severity of first-episode cases.1
Fusar-Poli P. Extending the Benefits of Indicated Prevention to Improve Outcomes of First-Episode Psychosis. JAMA Psychiatry. 2017;74(7):667–668. doi:10.1001/jamapsychiatry.2017.1009
Coronavirus Resource Center
Customize your JAMA Network experience by selecting one or more topics from the list below.
Create a personal account or sign in to: